$MNMD In a closing statement to Benzinga, early backer Kevin O’Leary — businessman, "Shark Tank" star, and co-founder of O’Shares ETFs — said: “MindMed is now entering later stage clinical trials and that takes a new type of leadership. I believe J.R. made the right decision to put his ego aside and passed the baton to a leader that is best for the company for the stage it's now at, as well as the many suffering from mental health and addiction.”
2
9
9 Likes